Company profile for Sancilio & Company Inc

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Sancilio and Company, Inc. (SCI) is a biopharmaceutical company focused on Advanced Lipid Technology™ (ALT) and complimentary products. Unlike most research stage companies, SCI has developed a portfolio of commercialized products that are developed, manufactured and distributed by our own dedicated people in our own cGMP manufacturing facilities. We are building all the necessary systems, facilities and expertise to allow u...
Sancilio and Company, Inc. (SCI) is a biopharmaceutical company focused on Advanced Lipid Technology™ (ALT) and complimentary products. Unlike most research stage companies, SCI has developed a portfolio of commercialized products that are developed, manufactured and distributed by our own dedicated people in our own cGMP manufacturing facilities. We are building all the necessary systems, facilities and expertise to allow us to maximize the value of our robust research pipeline that includes highly concentrated essential fatty acids, improvements to bioavailablility of these and other products.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Main Office: 3874 Fiscal Court, STE 100, Riviera Beach, FL 33404-1785, USA
Telephone
Telephone
1. 561.847-23022. 800.SCI.8711
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

http://www.prnewswire.com/news-releases/sancilio-pharmaceuticals-company-inc-spci-receives-rare-pediatric-disease-designation-from-the-us-food-and-drug-administration-for-altemia-a-treatment-of-sickle-cell-disease-scd-in-children-300522085.html

PR NEWSWIRE
19 Sep 2017

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty